Bank Of New York Mellon Corp Eye Point Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$2.28 - $5.04 $163,840 - $362,174	71,860 New	71,860 $211 Million
Q4 2022 Feb 14, 2023	BUY	$2.37 - $7.2 $189,713 - $576,345	80,048 New	80,048 $280,000
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.12 $51,420 - $82,154	7,388 Added 10.57%	77,317 $612,000
Q2 2022 Aug 15, 2022	SELL	$7.25 - $12.71 $68,715 - $120,465	-9,478 Reduced 11.94%	69,929 $550,000
Q1 2022 May 11, 2022	BUY	$8.67 - $14.11 $34,549 - $56,228	3,985 Added 5.28%	79,407 $966,000
Q4 2021 Feb 11, 2022	BUY	$10.18 - $18.4 $37,543 - $67,859	3,688 Added 5.14%	75,422 $923,000
Q3 2021 Nov 12, 2021	BUY	$7.51 - $11.72 $96,000 - $149,816	12,783 Added 21.68%	71,734 $747,000
Q2 2021 Aug 11, 2021	BUY	$8.69 - $11.08 $512,284 - $653,177	58,951 New	58,951 $529,000

163

58.2M

224K

1.41M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $272M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.